跳至主要内容
临床试验/IRCT20210524051384N6
IRCT20210524051384N6招募中3 期

Evaluation of the combined effect of intralesional injection of Triamcinolone and Verapamil in the treatment of post-surgery Keloid scars

Rasht University of Medical Sciences0 个研究点目标入组 16 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
16

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 50 years(—)
性别
All

入选标准

  • The Keloid scar should be at least 0.5 cm long and at most 10 cm
  • At least 3 months will be passed since their surgery
  • Patients are in the age range of 18 to 50 years
  • consent Informed

排除标准

  • Keloid scars with a duration of more than 12 months
  • Patients with infection or any other disease in the vicinity of the wound
  • Pregnant patients or those who plan to become pregnant in the near future
  • Breastfeeding women
  • Diabetic patients
  • Patients with high blood pressure or heart problems
  • People with chronic kidney disease or those who have had any abnormal changes in the CBC or liver tests
  • Patients taking steroids or verapamil for other conditions
  • Keloid scars of the head, face and neck

研究者

发起方
Rasht University of Medical Sciences

相似试验